-
Article
Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancer
To test the impact of carboplatin-based ACT on overall survival (OS) in patients with pN1-3 cM0 BCa.
-
Article
Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration
To compare cancer-specific mortality (CSM) and overall mortality (OM) between immediate radical cystectomy (RC) and Bacillus Calmette–Guérin (BCG) immunotherapy for T1 squamous bladder cancer (BCa).
-
Article
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study
Luteinizing hormone-releasing hormone (LHRH)-agonists in prostate cancer (PCa) patients induce sarcopenic obesity. The effect of LHRH-antagonist on body composition has never been explored. We evaluated change...
-
Article
Open AccessDelaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomes
This study was carried out to assess whether a prolonged time between primary transurethral resection of non-muscle-invasive bladder cancer (TURB) and implementation of bacillus Calmette–Guerin (BCG) immunothe...
-
Article
Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent
Adjuvant chemotherapy (ACT) is recommended for non-organ-confined bladder cancer (BCa) after radical cystectomy (RC) and pelvic lymph node dissection (PLND), but there are sparse data regarding its specific ef...
-
Article
Trends in risk-group distribution and Pentafecta outcomes in patients treated with nerve-sparing, robot-assisted radical prostatectomy: a 10-year low-intermediate volume single-center experience
To evaluate the trends in risk-group distribution and Pentafecta outcomes in patients treated with nerve-sparing (NS), robot-assisted radical prostatectomy (RARP) in a single low-intermediate volume prostate c...
-
Article
The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration
To assess the impact of perioperative chemotherapy on survival in cN+ BCa patients and analyze it according to the pN status.
-
Article
How to improve patient selection for neoadjuvant chemotherapy in bladder cancer patients candidate for radical cystectomy and pelvic lymph node dissection
To improve patient selection for neoadjuvant chemotherapy (NAC) before radical cystectomy (RC) in bladder cancer patients (BCa).
-
Article
The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy
To evaluate the role of a complete transurethral resection of bladder tumors (c-TURBT) on oncological outcomes after radical cystectomy (RC) and its relationship with adverse pathological features.
-
Article
Standard vs delayed ligature of the dorsal vascular complex during robot-assisted radical prostatectomy: results from a randomized controlled trial
Prospective randomized trial to compare standard vs delayed approach to dorsal vascular complex (s-DVC vs d-DVC) in robot-assisted radical prostatectomy (RARP).
-
Living Reference Work Entry In depth
Transurethral Resection of Bladder Cancer and Its Applications
Transurethral resection of bladder tumors (TURBT) is a procedure performed to diagnose and stage bladder cancer (BCa) and to resect all visible tumors. This chapter is focused on TURBT surgical technique, poss...
-
Reference Work Entry In depth
Transurethral Resection of Bladder Cancer and Its Applications
Transurethral resection of bladder tumors (TURBT) is a procedure performed to diagnose and stage bladder cancer (BCa) and to resect all visible tumors. This chapter is focused on TURBT surgical technique, poss...
